By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Circassia Pharma 

Northbrook House
Robert Robinson Avenue
The Oxford Science Park  Oxford  OX4 4GA  United Kingdom
Phone: n/a Fax: n/a



Start Up

Company News
Circassia (CIR.L) Announces Positive Outcome Of European Decentralised Procedure For Approval Of Its Fluticasone Propionate Equivalent Of GlaxoSmithKline (GSK)’s FLIXOTIDE pMDI 11/24/2015 10:19:19 AM
Circassia (CIR.L) Business Update 10/27/2015 12:18:48 PM
Circassia (CIR.L) Release: Interim Results For The Six Months Ended 30 June 2015 7/28/2015 8:50:12 AM
Circassia (CIR.L)’s Extended Offer Period For Aerocrine Has Increased Acceptances To 97.2 Percent 6/30/2015 9:28:55 AM
Circassia (CIR.L) Release: Completion Of Acquisition Of Prosonix 6/15/2015 10:18:50 AM
Circassia (CIR.L) Declares The Offer For Aerocrine Unconditional And Extends The Acceptance Period 6/15/2015 9:37:17 AM
Circassia (CIR.L) To Present At EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 6/4/2015 8:11:13 AM
Circassia (CIR.L) Drops $377 Million for Two Asthma Firms, Aerocrine and Prosonix 5/15/2015 6:02:17 AM
Circassia Limited (CIR.L) Interim Management Statement 11/11/2014 11:23:22 AM
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/13/2014 7:33:24 AM